BTIG Reiterates Buy on Biohaven, Raises Price Target to $28
Portfolio Pulse from Benzinga Newsdesk
BTIG analyst Thomas Shrader reiterated a Buy rating on Biohaven (NYSE:BHVN) and raised the price target from $24 to $28.
June 06, 2023 | 9:13 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
BTIG analyst Thomas Shrader reiterated a Buy rating on Biohaven and raised the price target from $24 to $28.
The news of BTIG reiterating a Buy rating and raising the price target for Biohaven is positive for the company's stock. This indicates that the analyst has confidence in the company's future performance and growth potential. As a result, this news is likely to have a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100